CA1310960C - Derives imidazole a activite antagoniste pour les recepteurs 5-ht3
- Google Patents
Derives imidazole a activite antagoniste pour les recepteurs 5-ht3
Info
Publication number
CA1310960C
CA1310960CCA000593777ACA593777ACA1310960CCA 1310960 CCA1310960 CCA 1310960CCA 000593777 ACA000593777 ACA 000593777ACA 593777 ACA593777 ACA 593777ACA 1310960 CCA1310960 CCA 1310960C
Authority
CA
Canada
Prior art keywords
formula
compound
hydrogen
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878723157Aexternal-prioritypatent/GB8723157D0/en
Application filed by Beecham Group PLCfiledCriticalBeecham Group PLC
Priority to CA000593777ApriorityCriticalpatent/CA1310960C/fr
Application grantedgrantedCritical
Publication of CA1310960CpublicationCriticalpatent/CA1310960C/fr
Certain N-azabicyclo-2,3-dihydro-indole-1-carboxamides having anti-emetic properties, further found useful in treating headaches, neuralgia and anxiety